Welcome: Guest | Site Use Options | Register | Login |

Xeris Pharmaceuticals Inc

Xeris Pharmaceuticals Inc

Profile last edited on: 12/10/2019
180 N LaSalle Street Suite 1810
Chicago, IL 60601
  (844) 445-5704
  bd@xerispharma.com
  www.xerispharma.com
Business Identifier: Developing non-aqueous formulations of injectable drugs
Public Profile:
Publicly traded since June 2018, Xeris Pharmaceuticals (NASDAQ:XERS) is a specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology. The company's disruptive formulation and delivery technologies allow for the subcutaneous delivery of highly concentrated, non-aqueous paste and liquid formulations of all drug classes, including small molecules, peptides, proteins, antibodies, and nucleic-acid-based therapeutics. he companys products include Xeris Glucagon, a glucagon rescue pen for severe hypoglycemia in type 1 and insulin-dependent type 2 diabetics; and Xeris G-Pen, a pre-loaded auto-injection pen with highly concentrated formulation. Its disruptive formulation-injection technologies allow the subcutaneous delivery of highly concentrated, paste, and liquid formulations of various drug classes, including small molecules, peptides, proteins, antibodies, and nucleotide-based therapeutics. Xeris Pharmaceuticals, Inc. also offers ready-to-use bio-pharmaceuticals delivered through injectable devices.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

WikiProfile

Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920

  support@inknowvation.com